The pooled results also indicated that FOXD2-AS1 expression was associated with bigger tumor size and advanced TNM stage, but was not related to age, gender, differentiation and lymph node metastasis. The gene discussed is FOXD2; the disease is metastatic malignant neoplasm in the lymph nodes.